Reminder: Theratechnologies Annual Meeting of Shareholders

(firmenpresse) - MONTREAL, CANADA -- (Marketwire) -- 05/15/12 -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THER) wishes to remind shareholders that its annual meeting of shareholders will be held tomorrow, Wednesday, May 16, 2012, at the Loews Vogue Hotel, 1425 rue de la Montagne, Montreal, Quebec, at 10:00 a.m., local time.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THER) is a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. Further information about Theratechnologies is available on the Company's website at , on SEDAR at and on the Securities and Exchange Commission's website at .



Contacts:
Roch Landriault
NATIONAL Public Relations
Phone: 514-843-2345

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 15.05.2012 - 14:00 Uhr
Sprache: Deutsch
News-ID 146694
Anzahl Zeichen: 0

contact information:
Town:

MONTREAL, CANADA

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 198 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Reminder: Theratechnologies Annual Meeting of Shareholders"
steht unter der journalistisch-redaktionellen Verantwortung von

Theratechnologies Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review ...

MONTREAL, QUEBEC -- (Marketwired) -- 11/13/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced that it was notified today by its partner, TaiMed Biologics, Inc. ("TaiMed"), that the U.S. Food and Drug Administration (&quo ...

Theratechnologies Announces Financial Results for Third Quarter of 2017 ...

MONTREAL, QUEBEC -- (Marketwired) -- 10/05/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2017.Third quarter 2017 financial highlights"With three quarters ...

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab P ...

MONTREAL, QUEBEC -- (Marketwired) -- 10/04/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced 48-week efficacy and safety results for ibalizumab in patients infected with multidrug resistant HIV-1 who completed the 24-week P ...

Alle Meldungen von Theratechnologies Inc.